Zubiri urges DOH: Try COVID-19 medicines used by other countries | Inquirer News

Zubiri urges DOH: Try COVID-19 medicines used by other countries

By: - Reporter / @KHallareINQ
/ 06:32 PM March 14, 2020

Sen. Juan Miguel Zubiri. FILE PHOTO

MANILA, Philippines — Senate Majority Leader Juan Miguel “Migz” Zubiri on Saturday urged the Department of Health (DOH) to let hospitals to try using the medicines that other countries use in effectively fighting the 2019 coronavirus disease (COVID-19).

https://www.facebook.com/migzzubiri/posts/3827390730612179?__xts__[0]=68.ARDb6x0eOrTG3fotHsHvbYhN3C7596lKGjI8haEFVtJ1_IerTm88SmKsrhNWzqC-ppiEjuzuLs_CtiCU_zo09_ZZA-Y7HoRn9RD9oXmzKdsyOGU9icGEfWyOHQPXfaqUXiKNqSenyhTEXjVzS3y1WO6DOfy5LNYLAUSpW7ur8emqm-eI8pPgl9YD01x844ajV-NxoSHbV-egjRGWsPVtvZkDoHxJQ69zW_cY1oPs9O0981sz0kNQb2EiJdRfy8oyYJo70RypQRf8N1gluKIZxMId9-IrZ3oaw984qUIxRp_wlu3Kbk31FkVUz8uU2eoRXuIABiVdzRYI5RmSJU5tig&__tn__=-R

Article continues after this advertisement

“Please, please, please try the drugs already in use by Thailand, Korea and India where it seems to be working and they have lessened their death rates: Lopinavir, ritonavir, oseltamivir, and chloroquine sulfate,” Zubiri said in his Facebook post.

FEATURED STORIES

The drugs he mentioned, however, have yet to be approved by the World Health Organization (WHO) nor by the DOH.

Zubiri added that the Philippines now has “one of the highest death rates of COVID-19 in the region at almost 10 percent.”

Article continues after this advertisement

As of Saturday, there have been eight recorded deaths of COVID-19 in the Philippines. Meanwhile, the country has a total of 98 positive coronavirus cases.

Article continues after this advertisement

“Pls make it an option in our hospitals as the other hospitals are waiting pa for the go signal of WHO,” Zubiri said. “If we wait, more people will die here in the country.”

Article continues after this advertisement

Zubiri added that patients should be allowed to sign a waiver to try the drugs, saying: “It should be an option they can take.”

Subject to regulatory standards

But the four drugs, as DOH Usec. Maria Rosario Vergeire said in a press briefing, will still be subjected to “regulatory standards.”

Article continues after this advertisement

“Ang regulatory standards po ay ginagamit ng kahit na anong bansa, o kahit na anong health system para masiguro na ang binibigay naming gamot ng ating mga kababayan ay ligtas at saka effective,” Vergeire explained.

(The regulatory standards are what any country or any health system uses to make sure that the medicine we give is safe and effective.)

“Para magamit natin ito, kailangan sumailalim na naman ito sa regulatory standards kung tama nga ba na ginagamit natin ay para sa sakit na COVID-19,” she added.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

(To use these, they have to undergo regulatory standards to see if they can be used for COVID-19).

Edited by JPV

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.